S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
CVE:OPS

Opsens Stock Forecast, Price & News

C$1.39
-0.01 (-0.71 %)
(As of 03/27/2017)
Add
Today's Range
C$1.35
C$1.40
50-Day Range
C$1.39
C$1.39
52-Week Range
C$1.11
C$1.83
Volume24,700 shs
Average Volume42,144 shs
Market CapitalizationC$101.46 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive OPS News and Ratings via Email

Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter.


Opsens logo

About Opsens

Opsens Inc. provides fiber optic sensing technology. The Company operates through two segments: Medical and Industrial. In Medical segment, the Company focuses on the measure of Fractional Flow Reserve (FFR) in interventional cardiology. In Industrial segment, it develops, manufactures and installs fiber optic sensing solutions for critical applications, such as the monitoring of oil wells and other industrial applications. It is also involved in industrial activities. For the FFR market, it has developed the OptoWire and OptoMonitor, instruments that assess the significance of arterial narrowing (stenosis) resulting from coronary heart disease. In the industrial sector, its technology and products can serve various markets, including aerospace, geotechnical, infrastructures, oil and gas, mining, laboratories and others. For the oil and gas market, it provides fiber optic sensor systems that provide real-time pressure and temperature measurements at the bottom of the wells.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
N/A
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$101.46 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.66 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Opsens (CVE:OPS) Frequently Asked Questions

Is Opsens a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Opsens stock.
View analyst ratings for Opsens
or view top-rated stocks.

What stocks does MarketBeat like better than Opsens?

Wall Street analysts have given Opsens a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Opsens wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Opsens' earnings last quarter?

Opsens Inc. (CVE:OPS) announced its earnings results on Thursday, June, 29th. The company reported ($0.02) earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.02). The company earned $4.89 million during the quarter.
View Opsens' earnings history
.

What price target have analysts set for OPS?

2 Wall Street analysts have issued 12 month price objectives for Opsens' shares. Their forecasts range from C$3.50 to C$6.00. On average, they anticipate Opsens' share price to reach C$4.75 in the next twelve months. This suggests a possible upside of 241.7% from the stock's current price.
View analysts' price targets for Opsens
or view top-rated stocks among Wall Street analysts.

Who are Opsens' key executives?

Opsens' management team includes the following people:
  • Denis M. Sirois, Independent Chairman of the Board
  • Louis Laflamme, President, Chief Executive Officer, Director
  • Robin Villeneuve, Chief Financial Officer
  • Thomas Keegan, President of Opsens Solutions Inc
  • Darren Wiltse, President of Opsens Solutions Inc.
  • George J. Quinoy, Vice President, General Manager - U.S. commercial sales and operations
  • Anthony Gibbons, Vice President of Sales and Marketing
  • Gaetan Duplain, Vice President - Oil and Gas, Director
  • Denis Harrington, Director
  • Pat Mackin, Director

What other stocks do shareholders of Opsens own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Opsens investors own include Abiomed (ABMD), Avesoro Resources (ASO), Canadian Zinc (CZN), Aecon Group (ARE), General Electric (GE), Zedcor (ZDC), Midland Exploration (MD), GUD (GUD), DHX Media (DHX.A) and Corus Entertainment (CJR.B).

What is Opsens' stock symbol?

Opsens trades on the Canadian Venture Exchange (CVE) under the ticker symbol "OPS."

How do I buy shares of Opsens?

Shares of OPS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Opsens' stock price today?

One share of OPS stock can currently be purchased for approximately C$1.39.

How much money does Opsens make?

Opsens has a market capitalization of C$101.46 million.

What is Opsens' official website?

The official website for Opsens is opsens.com.

Where are Opsens' headquarters?

How can I contact Opsens?

Opsens' mailing address is 750 du Parc-Technologique Blvd, QUEBEC, QC G1P 4S3, Canada. The company can be reached via phone at +1-418-7810333.


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.